Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brian Tierney

Plastic Surgery Nashville, TN Medical Doctor

NPI 1265440416 CMS profile 328891

2004 Hayes Street, Suite 315, Nashville, TN 37203

Open in the dashboard

General payments

$51,925

466 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$127,300 paid to institutions, not to them · program years 2020–2021

Through program year 2025, Brian Tierney of Nashville, TN is reported in the CMS Open Payments database as having received $51,925 across 466 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $127,300 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,748 74
2024 General $2,927 69
2023 General $2,890 41
2022 General $2,339 45
2021 General $33,890 24
2020 General $3,829 87
2019 General $2,302 126

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brian Tierney
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Brian Tierney were reported at $3,748. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Brian Tierney Plastic Surgery median Middle half National median
2019 $2,302 $371 $122–$1,483 $163
2020 $3,829 $158 $52–$438 $114
2021 $33,890 $249 $87–$752 $132
2022 $2,339 $274 $102–$793 $149
2023 $2,890 $299 $113–$891 $160
2024 $2,927 $361 $124–$1,062 $164
2025 $3,748 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Aziyo Biologics, Inc. $38,908 12 payments
  2. RTI Surgical, Inc $3,808 34 payments
  3. Allergan Inc. $3,259 192 payments
  4. Integra LifeSciences Corporation $1,167 18 payments
  5. AbbVie, Inc. $1,086 78 payments
  6. Mentor Worldwide LLC $909 46 payments
  7. Sientra, Inc. $887 23 payments
  8. TELA Bio, Inc. $749 26 payments
  9. Motiva USA, LLC $306 8 payments
  10. Innovation Technologies Inc $251 3 payments
  11. Other $595 26 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $36,563 6 payments
  2. Food and Beverage $13,034 456 payments
  3. Honoraria $2,003 3 payments
  4. Long term medical supply or device loan $326 1 payment
Products named General payments · program years 2019–2025
  1. CORTIVA ALLOGRAFT DERMIS $3,115 27 payments
  2. NATRELLE $2,883 166 payments
  3. ECM Patch,Pouch $2,330 5 payments
  4. SimpliDerm ,Integuply $2,025 2 payments
  5. NATRELLE SALINE-FILLED BREAST IMPLANTS $912 60 payments
  6. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $887 23 payments
  7. DuraSorb Monofilament Mesh $699 10 payments
  8. ALLOGRAFT $692 7 payments
  9. MENTOR MemoryGel Resterilizable Gel Sizer $608 28 payments
  10. ARTOURA Breast Tissue Expander $424 19 payments
  11. Other $4,461 153 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

204

Median for Plastic and Reconstructive Surgery: 61

Drug cost

$859

Median for Plastic and Reconstructive Surgery: $369

Branded share of claims

35.8%

Median for Plastic and Reconstructive Surgery: 30%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Doxycycline Hyclate Generic 103 $475
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 62 $231
Mupirocin Generic 13 $77
Fluconazole Generic 15 $47
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 11 $29

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,638 Part D prescribers listed as Plastic and Reconstructive Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 29 billing codes

Paid by Medicare

$78,563

Medicare's payments for the services billed

Medicare patients

66

Average age 71

Services billed

291

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Cancer 75%
High blood pressure 58%
Arthritis 36%
Osteoporosis 30%
Diabetes 29%
Depression 24%
Chronic kidney disease 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

466 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record